Home > Synthetic benzimidazole opioids: the emerging health challenge for European drug users.

Di Trana, Annagiulia and Pichini, Simona and Pacifici, Roberta and Giorgetti, Raffaele and Busardò, Francesco Paolo (2022) Synthetic benzimidazole opioids: the emerging health challenge for European drug users. Frontiers in Psychiatry, 13, 858234. https://doi.org/10.3389/fpsyt.2022.858234.

External website: https://www.frontiersin.org/journals/psychiatry/ar...


The new psychoactive substances (NPS) phenomenon was initially observed as a response of the illicit market to the international ban on classic drugs of abuse, with the peculiarity of a continuous release of new uncontrolled compounds exerting psychotropic effects which in some cases resulted more potent or longer lasting than those of classic abused substances (1). To date, more than 1,100 NPS have been characterized, mainly new synthetic cathinones and new synthetic cannabinoids, even if the most recent emerging trend has been that of new synthetic opioids (NSOs)...

Item Type
Article
Publication Type
International, Open Access, Article
Drug Type
Opioid, New psychoactive substance
Intervention Type
Harm reduction
Date
March 2022
Identification #
https://doi.org/10.3389/fpsyt.2022.858234
Volume
13
EndNote

Repository Staff Only: item control page